People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Pharma, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Halda Therapeutics, LLC | — | Pharma | Series D+ | $197.9M | $1.3B | 2021 |
| Siduma Therapeutics, Inc. | — | Biotechnology | Series B | $31.2M | $687.1M | 2021 |
Rebecca Frey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rebecca Frey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Shannon | 1 | 9 |
| Tim Shannon | 1 | 9 |
| Craig Crews | 1 | 6 |
| Arjun Goyal | 1 | 5 |
| Scott Phillips | 1 | 5 |
| Nandita Shangari | 1 | 4 |
| Liam Ratcliffe | 1 | 4 |
| Rebecca Luse | 1 | 3 |
| Joe Cabral | 1 | 2 |
| Wei Zhao | 1 | 2 |
| Leyi Wang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.